What if there was a program that connected surgeons, physicians, nursing staff, and other medical care providers with a team of the nation’s top engineers? What if that program enabled the transfer of innovative ideas to working prototypes – financially and developmentally?
Seth Mailhot, J.D., of Michael Best and Friedrich, LLP, visited Vanderbilt University earlier this week and shared understanding of the newly released FDA guidelines on medical software, apps, and devices. The seminar was well-attended and quite engaging, with dozens of engineers, medical researchers, students, and other staff bringing great questions to the conversation.
November 17 is designated World Prematurity Day, and is intended to bring light to a stubborn global problem. Premature birth is the leading cause of neonatal death worldwide, with an estimated 15 million babies born premature.
Tuesday, Nov. 19, CTTC will host a special seminar, "When Does a Medical Software/APP Become a Medical Device: Practical Considerations and FDA Guidance”. Leading the seminar will be Seth Mailhot, J.D., attorney at Michael Best and Friedrich, LLP.
They may not have walked away with the million dollar award, but the founders of InvisionHeart gained irreplaceable knowledge and experience from the 2013 Global Food and Health Innovation Challenge. CEO and co-founder Josh Nickols, Ph.D., took the stage to tell a panel of judges why they should invest the innovation award in his company's wireless EKG system.
The month of October ended with three Vanderbilt technologies earning patent protection from the USPTO. The most recent patent awarded was for a compound that may help treat major depressive disorder and other neurological disorders. It was developed at the Vanderbilt Center for Neuroscience Drug Discovery by VCNDD Director P.
Dozens of faculty members, students, entrepreneurs and innovators from the Middle Tennessee region convened at the Cool Springs Life Sciences Center for a two-hour session on intellectual property valuation and new venture valuation. While having broader applicability, the presentations focused on life sciences technologies and businesses.
Today International FemtoScience, Inc., a Vanderbilt startup, signed a patent license agreement with Vanderbilt and TVA. The technology involved is that of nanodiamond additives to transformer oil for improved cooling performance.
Three national organizations have teamed up to help bring breast cancer technologies to market. October 1, 2013, Avon Foundation for Women, in partnership with the National Cancer Institute and the Center for Advancing Innovation, kicked off a nationwide start-up challenge.
Cancer can grow anywhere in the human body, but we often hear of certain types that are more likely to metastasize, or spread. Breast cancer is one of those, and the reason lies in the proximity to the body’s lymph nodes. If breast cancer metastasizes, it can easily and quickly spread. This is why early and frequent screenings are critical in helping women stave off the disease.
Much is underway in Tennessee to promote and support the life sciences industry including its underlying sources of support: research, scientists and entrepreneurship. Life Science Tennessee, a statewide trade group, is helping to lead the charge by connecting companies, academia, research institutions, government and economic development, and other industry associations.
One quarter into the new fiscal year, more than a dozen Vanderbilt technologies have been awarded patent protection by the USPTO. The four newest, which were issued throughout the month of September, include:
REDCap, a prospective Vanderbilt startup based on a comprehensive electronic data capture (EDC) solution, is one of just five new ventures selected to compete in this year's Life Science TN Venture Pitch Forum.
For Byron Smith, his graduate-level research was personal. After losing his father to cancer, he was eager to explore ways to make colonoscopy less dreaded and increase the number of people who get screened for Colorectal Cancer each year. As his collaborator and former professor Pietro Valdastri quickly pointed out, early screening is key to saving lives.
Four new patents protecting Vanderbilt intellectual property were assigned during the month of August. The technologies represent fields such as neuroscience, cellular biology, molecular biology, cancer therapy, and diagnostics. They are:
Five Vanderbilt inventions received patent protection from the USPTO in July. The technologies represent a variety of fields, including cell biology, molecular biology, cancer therapy, neuroscience, and vaccine production, among others.